[go: up one dir, main page]

SE0300187D0 - A smokeless tobacco substitute material - Google Patents

A smokeless tobacco substitute material

Info

Publication number
SE0300187D0
SE0300187D0 SE0300187A SE0300187A SE0300187D0 SE 0300187 D0 SE0300187 D0 SE 0300187D0 SE 0300187 A SE0300187 A SE 0300187A SE 0300187 A SE0300187 A SE 0300187A SE 0300187 D0 SE0300187 D0 SE 0300187D0
Authority
SE
Sweden
Prior art keywords
active substance
biologically active
ionic
carbohydrate
solvent
Prior art date
Application number
SE0300187A
Other languages
Swedish (sv)
Inventor
Ingemar Jonsson
Hans-Henrik Lidgard
Original Assignee
Magle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magle Ab filed Critical Magle Ab
Priority to SE0300187A priority Critical patent/SE0300187D0/en
Publication of SE0300187D0 publication Critical patent/SE0300187D0/en
Priority to SE0302947A priority patent/SE0302947D0/en
Priority to DK04704787.3T priority patent/DK1617823T3/en
Priority to SI200432466T priority patent/SI1617823T1/en
Priority to UAA200508282A priority patent/UA86758C2/en
Priority to AU2004206199A priority patent/AU2004206199B2/en
Priority to EA200501168A priority patent/EA012306B1/en
Priority to ES04704787T priority patent/ES2718634T3/en
Priority to JP2006500759A priority patent/JP5283334B2/en
Priority to US10/543,856 priority patent/US8846075B2/en
Priority to EP04704787.3A priority patent/EP1617823B1/en
Priority to PT04704787T priority patent/PT1617823T/en
Priority to ZA200505872A priority patent/ZA200505872B/en
Priority to KR1020057013656A priority patent/KR20050107401A/en
Priority to CN2004800028139A priority patent/CN1741791B/en
Priority to PCT/SE2004/000091 priority patent/WO2004064811A1/en
Priority to CA2514325A priority patent/CA2514325C/en
Priority to HUE04704787A priority patent/HUE042680T2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)

Abstract

The invention refers to a composition material that is intended for rapid transmucosal delivery in the mouth of a biologically active substance when in contact with saliva. The composition material comprises at least one ionic carbohydrate, having at least one biologically active substance ionically bound thereto, and at least one wetable non-soluble polymeric carbohydrate. The invention also refers to a method of preparing the composition material, which comprises the steps of: (a) providing a mixture of the at least one biologically active substance and at least one ionic carbohydrate in a solvent having a permissive pH for ionic bonding of the at least one biologically active substance to the at least one ionic carbohydrate; (b) mixing the mixture in the solvent for a period that is sufficient for allowing the ionic bonding to take place; and (c) recovering the mixture from the solvent.
SE0300187A 2003-01-24 2003-01-24 A smokeless tobacco substitute material SE0300187D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE0300187A SE0300187D0 (en) 2003-01-24 2003-01-24 A smokeless tobacco substitute material
SE0302947A SE0302947D0 (en) 2003-01-24 2003-11-07 A composition material for transmucosal delivery
HUE04704787A HUE042680T2 (en) 2003-01-24 2004-01-23 A pouch comprising a nicotine composition for transmucosal delivery
JP2006500759A JP5283334B2 (en) 2003-01-24 2004-01-23 Composition material for transmucosal transmission
US10/543,856 US8846075B2 (en) 2003-01-24 2004-01-23 Composition material for transmucosal delivery
UAA200508282A UA86758C2 (en) 2003-01-24 2004-01-23 Composition material for transmucosal delivery
AU2004206199A AU2004206199B2 (en) 2003-01-24 2004-01-23 A composition material for transmucosal delivery
EA200501168A EA012306B1 (en) 2003-01-24 2004-01-23 A composition material for transmucosal delivery
ES04704787T ES2718634T3 (en) 2003-01-24 2004-01-23 A bag comprising a nicotine composition for transmucosal administration
DK04704787.3T DK1617823T3 (en) 2003-01-24 2004-01-23 POSE INCLUDING A NICOTINE PREPARATION FOR TRANSMUCOSAL ADMINISTRATION
SI200432466T SI1617823T1 (en) 2003-01-24 2004-01-23 A pouch comprising a nicotine composition for transmucosal delivery
EP04704787.3A EP1617823B1 (en) 2003-01-24 2004-01-23 A pouch comprising a nicotine composition for transmucosal delivery
PT04704787T PT1617823T (en) 2003-01-24 2004-01-23 A composition material for transmucosal delivery
ZA200505872A ZA200505872B (en) 2003-01-24 2004-01-23 A composition material for transmucosal delivery
KR1020057013656A KR20050107401A (en) 2003-01-24 2004-01-23 A composition material for transmucosal delivery
CN2004800028139A CN1741791B (en) 2003-01-24 2004-01-23 A composition material for transmucosal delivery
PCT/SE2004/000091 WO2004064811A1 (en) 2003-01-24 2004-01-23 A composition material for transmucosal delivery
CA2514325A CA2514325C (en) 2003-01-24 2004-01-23 A composition material for transmucosal delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300187A SE0300187D0 (en) 2003-01-24 2003-01-24 A smokeless tobacco substitute material

Publications (1)

Publication Number Publication Date
SE0300187D0 true SE0300187D0 (en) 2003-01-24

Family

ID=20290214

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300187A SE0300187D0 (en) 2003-01-24 2003-01-24 A smokeless tobacco substitute material

Country Status (4)

Country Link
CN (1) CN1741791B (en)
SE (1) SE0300187D0 (en)
UA (1) UA86758C2 (en)
ZA (1) ZA200505872B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101528199B (en) * 2006-03-16 2013-05-29 尼科诺瓦姆股份公司 Improved snuff composition
AU2009271271A1 (en) * 2008-06-23 2010-01-21 Biodelivery Sciences International, Inc. Multidirectional mucosal delivery devices and methods of use
US20170258710A1 (en) * 2016-03-11 2017-09-14 Intelgenx Corp. Montelukast transmucosal film

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5167244A (en) * 1990-01-19 1992-12-01 Kjerstad Randy E Tobacco substitute
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
WO1996000072A1 (en) * 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
US5656284A (en) * 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it

Also Published As

Publication number Publication date
CN1741791B (en) 2011-11-16
CN1741791A (en) 2006-03-01
ZA200505872B (en) 2006-10-25
UA86758C2 (en) 2009-05-25

Similar Documents

Publication Publication Date Title
SE0302947D0 (en) A composition material for transmucosal delivery
WO2004064811A8 (en) A composition material for transmucosal delivery
ATE234607T1 (en) METHOD AND COMPOSITIONS WITH IMPROVED BIOAVAILABILITY OF BIOACTIVE INGREDIENTS FOR MUCOSAL DELIVERY
EP2409707B8 (en) Polymer-based sustained release device
LT2003107A (en) Pulmonary adminstration of chemically modified insulin
AU2002360097A1 (en) Tobacco and/or tobacco substitute composition for use as a snuff in the oral cavity
MXPA04005517A (en) Pharmaceutical compositions in the form of gel or solution based on dihydrotestosterone, preparation method and uses thereof.
IL143706A0 (en) Polyol/oil suspensions for the sustained release of proteins
TW200501941A (en) Heterobifunctional polymeric bioconjugates
CY1109168T1 (en) COMPOSITION OF HIGH-CLEAR FONTAPARINOX Sodium
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
NZ533060A (en) Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
AU7931301A (en) Method of using diketopiperazines and composition containing them
TNSN07237A1 (en) CONJUGATES OF IGF-1 AND POLY (ETHYLENE GLYCOL)
WO2006065951A3 (en) Sustained delivery formulations of octreotide compounds
WO2006089993A3 (en) Method of obtaining hydrogels of cyclodextrins with glycidyl ethers, compositions thus obtained and applications thereof
WO2006052790A3 (en) Biodegradable linkers for molecular therapies
SG179459A1 (en) Tablet containing steroid hormones
HK1141444A1 (en) Composition for transmucosal delivery of polypeptides
WO2000050046A8 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
DE69819145D1 (en) BIO-DEGRADABLE MICROPARTICLES WITH DELAYED ACTIVE SUBSTANCE RELEASE
WO2003089458A3 (en) Conjugates of membrane translocating agents and pharmaceutically active agents
SE0300187D0 (en) A smokeless tobacco substitute material
AU2003255275A1 (en) Improved anthrax vaccines and delivery methods
AU2001258662A1 (en) Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds